Seguro Surgical obtains global marketing rights to use a novel abdominal surgery device

Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.

Over two million abdominal surgeries (laparotomies) are performed annually in the United States. Current practice utilizes cotton towels or sponges to reposition the bowel and allow access to the surgical area. This procedure is time consuming, presents potential safety risks to patients and can lead to post-operative complications. Seguro's "Lap-Pak" device is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site.

The device was developed by surgeons and biomedical engineering students from the BME undergraduate design course at Johns Hopkins under the leadership of Robert E. Bristow, M.D., M.B.A., Professor, Director, Kelly Gynecological Oncology Service and Director, Johns Hopkins Ovarian Cancer Center of Excellence.

Dr. Steve Kubisen, President and Chief Executive Officer of Seguro, stated, "We believe that this elegantly simple device will improve the overall efficiency of laparotomies and generate substantial reductions in overall healthcare costs. We are very excited to be working with Johns Hopkins and hope that this will be the first of many collaborative ventures that we undertake together."

Source:

Seguro Surgical, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Stem-cell implants restore vision in patients with corneal stem cell deficiency